Back
Vanda Pharmaceuticals Quote, Financials, Valuation and Earnings
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
40
VNDA
Vanda Pharmaceuticals
Last Price:
4.89
Seasonality Move:
7.58%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Vanda Pharmaceuticals Price Quote
$4.89
Vanda Pharmaceuticals Key Stats
Sell
40
Vanda Pharmaceuticals (VNDA)
is a Sell
Day range:
$4.72 - $4.91
52-week range:
$3.30 - $6.75
Dividend yield:
0%
P/E ratio:
119.75
P/S ratio:
1.52
P/B ratio:
0.51%
Volume:
863.4K
Avg. volume:
595K
1-year change:
9.64%
Market cap:
$279.2M
Revenue:
$192.6M
EPS:
$-0.19
How Much Does Vanda Pharmaceuticals Make?
-
How Much Are Vanda Pharmaceuticals's Sales Annually?
VNDA Revenues are $192.6M -
How Much Profit Does Vanda Pharmaceuticals's Make A Year?
VNDA net income is $2.5M
Is Vanda Pharmaceuticals Growing As A Company?
-
What Is Vanda Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is Vanda Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Vanda Pharmaceuticals Stock Price Performance
-
Did Vanda Pharmaceuticals Stock Go Up Last Month?
Vanda Pharmaceuticals share price went up by 5.62% last month -
Did VNDA's Share Price Rise Over The Last Year?
VNDA share price rose by 9.64% over the past 1 year
What Is Vanda Pharmaceuticals 52-Week High & Low?
-
What Is Vanda Pharmaceuticals’s 52-Week High Share Price?
Vanda Pharmaceuticals has traded as high as $6.75 over the past 52 weeks -
What Is Vanda Pharmaceuticals’s 52-Week Low Share Price?
Vanda Pharmaceuticals has traded as low as $3.30 over the past 52 weeks
Vanda Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Vanda Pharmaceuticals?
-
How Much Debt Does Vanda Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Vanda Pharmaceuticals Have?
Cash and short term investments quarterly total is $387.7M -
What Is Vanda Pharmaceuticals’s Book Value Per Share?
Book value per share is 9.31
Is Vanda Pharmaceuticals Cash Flow Positive?
-
What Is VNDA Cash Flow From Operations?
Cash flow from operations (TTM) is -$5.1M -
What Is Vanda Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Vanda Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$41.9M
Vanda Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
VNDA return on invested capital is -2.01% -
What Is Vanda Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -1.69% -
What Is VNDA Return On Equity?
ROE is a measure of profitability and is -2.01%
Vanda Pharmaceuticals Earnings Date & Stock Price
-
What Is Vanda Pharmaceuticals's Stock Price Today?
A single share of VNDA can be purchased today for 4.89 -
What Is Vanda Pharmaceuticals’s Stock Symbol?
Vanda Pharmaceuticals trades on the nasdaq under the ticker symbol: VNDA -
When Is Vanda Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Vanda Pharmaceuticals is scheduled on February 7, 2025 -
When Is VNDA's next ex-dividend date?
Vanda Pharmaceuticals's next ex-dividend date is May 27, 2020 -
How To Buy Vanda Pharmaceuticals Stock?
You can buy Vanda Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Vanda Pharmaceuticals Competitors
-
Who Are Vanda Pharmaceuticals's Competitors?
Below is a list of companies who compete with Vanda Pharmaceuticals or are related in some way:
Vanda Pharmaceuticals Dividend Yield
-
What Is VNDA Dividend Yield?
Vanda Pharmaceuticals’s dividend yield currently is 0% -
What Is Vanda Pharmaceuticals’s Payout Ratio?
Vanda Pharmaceuticals’s payout ratio is 0% -
When Did Vanda Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 7, 2024 -
What Is Vanda Pharmaceuticals’s Dividend Per Share?
Vanda Pharmaceuticals pays a dividend of $0.00 per share
Vanda Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 9.59% | 5.46% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 10.55 |
| Upside from Last Price: | 115.8% |